Although some cancer genes show high mutation frequencies (such as TP53 or KRAS, both well-known cancer genes), previous studies demonstrate that extensive inter-patient heterogeneity is present in various types of cancers9 and some cancer genes are mutated in a small number of samples16–18. This evidence concerns the gene TP53 and cancer.